Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL482738 | 0.86 | FFAR3 (0.39) | GLAKMT2AATMCA12CA1 | |
| Acetic Acid SCHEMBL21834859 | 0.86 | FFAR3 (0.39) | GLAKMT2AATMCA12CA1 | |
| SCHEMBL28011755 | 0.84 | GLA (0.34) | GLAKMT2AATMCA12CA1 | |
| Methyl Alcohol SCHEMBL28183931 | 0.83 | BRD4 (0.33) | GLACA12CA1CA9 | |
| SCHEMBL338264 | 0.83 | KDM4E (0.34) | CA12CA1CA9 | |
| SCHEMBL785147 | 0.83 | — | — | |
| Bicarbonate SCHEMBL14917 | 0.80 | CA1 (0.38) | CA12CA1CA9 | |
| Bicarbonate SCHEMBL6150295 | 0.80 | CA1 (0.38) | CA12CA1CA9 | |
| SCHEMBL3904196 | 0.80 | GLA (0.32) | GLA | |
| SCHEMBL23174460 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2031392-B1 | Use of chondroitin sulphate to reduce non-specific binding in Troponin I immunoassays | ORTHO CLINICAL DIAGNOSTICS INC (US) | 2014-09-24 | — | — | EP | disclosed |
| US-8617820-B2 | Use of glycosaminoglycans to reduce non-specific binding in immunoassays | ORTHO-CLINICAL DIAGNOSTICS, INC. (US) | 2013-12-31 | — | — | US | disclosed |
| US-20090061455-A1 | Use of Glycosaminoglycans to Reduce Non-Specific Binding in Immunoassays | QUIDEL CORPORATION | 2009-03-05 | — | — | US | disclosed |
| EP-2031392-A1 | Use of glycosaminoglycans to reduce non-specific binding in immunoassays | Ortho-Clinical Diagnostics, Inc. (US) | 2009-03-04 | — | — | EP | disclosed |